Insider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Buys 1,876 Shares of Stock
MarketBeat
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) Director Ra Capital Management, L.P. bought 1,876 shares of Artiva Biotherapeutics stock in a transaction on Friday, June 26th. The shares were purchased at an average price of $8.98 per share, for a total transaction of $16,846.48. Following the acquisition, the director directly owned 16,795,919 shares in the company, valued at approximately $150,827,352.62. This trade represents a 0.01% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.
NASDAQ:ARTV
